Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hyperfine Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
HYPR
Nasdaq
3845
https://hyperfine.io/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hyperfine Inc
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
- Apr 23rd, 2024 1:00 pm
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
- Apr 17th, 2024 1:00 pm
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 21st, 2024 8:05 pm
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
- Mar 12th, 2024 1:00 pm
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
- Mar 7th, 2024 9:30 pm
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
- Feb 28th, 2024 9:30 pm
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
- Feb 21st, 2024 2:00 pm
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
- Feb 1st, 2024 1:00 pm
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use
- Jan 9th, 2024 2:00 pm
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
- Nov 20th, 2023 2:00 pm
Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 16th, 2023 2:00 pm
Hyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 3:10 pm
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 9:05 pm
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients
- Nov 2nd, 2023 1:15 pm
Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023
- Oct 19th, 2023 8:05 pm
Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives
- Oct 10th, 2023 8:05 pm
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
- Oct 9th, 2023 1:00 pm
Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase
- Sep 7th, 2023 8:05 pm
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
- Aug 14th, 2023 8:05 pm
Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System
- Aug 9th, 2023 1:00 pm
Scroll